photo of

Details

Role Group Leader / Principal Research Fellow
Associate Professor Paul Licciardi is Group Leader in the Vaccine Immunology group at MCRI.
Associate Professor Paul Licciardi is Group Leader in the Vaccine Immunology group at MCRI.

Top Publications

  • Tosif, S, Haycroft, ER, Sarkar, S, Toh, ZQ, Anh-ha, DL, Donato, CM, Selva, KJ, Hoq, M, Overmars, I, Nguyen, J, et al. Virology and immune dynamics reveal high household transmission of ancestral SARS-CoV-2 strain. 2024
    view publication
  • Niyomnaitham, S, Chatsiricharoenkul, S, Toh, ZQ, Senawong, S, Pheerapanyawaranun, C, Phumiamorn, S, Licciardi, PV, Chokephaibulkit, K. Evaluation of the safety and immunogenicity of fractional intradermal COVID-19 vaccines as a booster: A pilot study. 2024
    view publication
  • Chatsiricharoenkul, S, Niyomnaitham, S, Posen, HJ, Toh, ZQ, Licciardi, PV, Wongprompitak, P, Duangchinda, T, Pakchotanon, P, Chantima, W, Chokephaibulkit, K. Safety and Immunogenicity of Intradermal Administration of Fractional Dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as Primary Series Vaccination. 2024
    view publication
  • Toh, ZQ, Mazarakis, N, Nguyen, J, Higgins, RA, Anderson, J, Ha, LA, Burgner, DP, Curtis, N, Steer, AC, Mulholland, K, et al. Comparison of antibody responses to SARS-CoV-2 variants in Australian children. 2024
    view publication
  • Niyomnaitham, S, Chatsiricharoenkul, S, Toh, ZQ, Senawong, S, Pheerapanyawaranun, C, Phumiamorn, S, Licciardi, PV, Chokephaibulkit, K. Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study. Vaccines 10(9) : 1497 2024
    view publication

Page 8 of 35